Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Anophthalmia and Microphthalmia Companies

ID: MRFR/HC/3302-HCR
200 Pages
Vikita Thakur
Last Updated: February 16, 2025
Anophthalmia and microphthalmia are rare congenital conditions characterized by the absence or underdevelopment of one or both eyes. Companies involved in the field of genetic disorders, rare diseases, and ophthalmology may contribute to research, development of treatments, and support for individuals affected by these conditions. 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anophthalmia and Microphthalmia Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.86%
2024 Market Size$ 0.89 Billion
2025 Market Size$ 0.93 Billion
2035 Market Size$ 1.5 Billion
Key Players
Novartis
Bausch Health Companies
Santen Pharmaceutical
Regeneron Pharmaceuticals
Aerie Pharmaceuticals
Horizon Therapeutics
Opportunities
  • Rising Awareness and Advocacy Efforts
  • Growing Demand for Supportive Care Services
  • Increased Funding for Research and Development

Top Industry Leaders in the Anophthalmia and Microphthalmia Market

Anophthalmia and microphthalmia Market
 

Latest Anophthalmia and Microphthalmia Companies Updates:

Santen Pharmaceutical Developing gene therapy for Leber's congenital amaurosis, a rare eye disease with potential applications for other eye conditions.

Alnylam Pharmaceuticals Leading the way in RNA interference technology, which has potential for treating genetic diseases affecting the eyes.

Bausch + Lomb A major player in ophthalmic devices, including prosthetics and implants, relevant to Anophthalmia and Microphthalmia patients.

List of Anophthalmia and Microphthalmia Key companies in the market:

  • Bristol-Myers Squibb Company
  • NUSAPURE
  • ALLERGAN
  • Aerie Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Bayer AG
  • Genentech, Inc.
  • Novartis AG 
  • Regeneron Pharmaceuticals, Inc.
  • Shire,
  • Santen Pharmaceutical Co., Ltd.
Get In-Depth Insights on Key Anophthalmia and Microphthalmia Companies